Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Visceral leishmaniasis – VZV infection - Hematology Quiz – Case 49

Autor: L Papageorgiou, J V Asimakopoulos, V Telonis, A Zannou, P M Arapaki, T Giannikos, E Nikolaou, G Dryllis, I Konstantinou, A Benekou, G Gainarou, P Flevari, E Sinni, P Tsaftaridis, E Plata, T P Vassilakopoulos, M K Angelopoulou, K Konstantopoulos, J Meletis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbee25d0df07986d894a018b7ae72fc8

Zobrazit plný text záznamu

Transplantation strategies for the management of patients with myelodysplastic syndromes

Autor: J, Meletis, E, Terpos

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 14(4)

Allogeneic stem cell transplantation (SCT) is the only therapeutic modality at present that may be delivered with curative intent in patients with myelodysplastic syndromes (MDS). Allogeneic CST replaces recipient dysplastic hemopoiesis with healthy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1ee8a83a48e11d20d8206b26209b85c2
https://pubmed.ncbi.nlm.nih.gov/20148443

Zobrazit plný text záznamu

FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study

Autor: K, Lilakos, N A, Viniou, D, Mavrogianni, T P, Vassilakopoulos, M N, Dimopoulou, E, Plata, M K, Angelopoulou, E, Variami, N, Stavrogianni, D, Liapi, I, Xilouri, A, Galanopoulos, M, Ageloudi, P, Panayiotidis, M, Voulgarelis, J, Rombos, J, Meletis, X, Yataganas, G A, Pangalis

Publikováno v: Anticancer research. 26(2A)

Activating mutations of the FLT3 receptor tyrosine kinase are common in acute promyelocytic leukemia (APL) but have uncertain prognostic significance. Information regarding FLT3 expression levels in APL without FLT3 mutations is lacking.Using RT-PCR,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::576306331281ff891c3b2055498938c9
https://pubmed.ncbi.nlm.nih.gov/16619525

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia

Autor: K, Anargyrou, G, Paterakis, D, Boutsis, M, Politou, S I, Papadhimitriou, M, Siakandaris, J, Vassiliadis, A, Androulakis, J, Meletis, J, Rombos, A, Tassiopoulou, G, Vaiopoulos

Publikováno v: European journal of haematology. 71(4)

Type 2 dendritic cell (DC2) acute leukemia has been recently described. We report here an unusual case of a 17-yr-old adolescent with overlapping features of DC2 and myeloid/NK cell precursor acute leukemia as defined by Suzuki et al. The patient pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::25ec6a1ae65255d98d452ac9fbe8fb9e
https://pubmed.ncbi.nlm.nih.gov/12950240

Zobrazit plný text záznamu

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta(2)-microglobulin in multiple myeloma

Autor: Terpos, E Viniou, N de la Fuente, J Meletis, J and Voskaridou, E Karkantaris, C Vaiopoulos, G Palermos, J and Yataganas, X Goldman, JM Rahemtulla, A

Objectives : Bisphosphonates have been found to reduce skeletal events in patients with multiple myeloma (MM). This is the first randomised trial to compare the efficacy of pamidronate and ibandronate, a third-generation aminobisphosphonate, in bone

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::c5510ec306bd62ab2c210d3533f2ffd1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3082905

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma

Autor: E, Terpos, J, Palermos, K, Tsionos, K, Anargyrou, N, Viniou, P, Papassavas, J, Meletis, X, Yataganas

Publikováno v: European journal of haematology. 65(5)

Bisphosphonates are potent inhibitors of osteoclastic activity and are used in the treatment of multiple myeloma (MM) in combination with chemotherapy. The effect of pamidronate on markers of bone resorption [cross-linked N-telopeptides of type I col

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4ba7ce76bc1ab1f699810b313a3ff094
https://pubmed.ncbi.nlm.nih.gov/14703700

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání